Company Filing History:
Years Active: 2019-2023
Title: Andrew M Intlekofer: Innovator in Stress-Induced Metabolism
Introduction
Andrew M Intlekofer is a notable inventor based in New York, NY (US). He has made significant contributions to the field of stress-induced metabolism, particularly through his innovative research and patents. With a total of 2 patents, Intlekofer's work focuses on understanding and treating stress-induced injuries.
Latest Patents
His latest patents include groundbreaking methods and compositions for diagnosing and treating stress-induced injuries, specifically hypoxia. The present invention is based on the novel discovery that a metabolite, L-2-hydroxyglutarate, along with certain enzymes and substrates regulating its metabolism, mediates stress-induced cellular mechanisms. These methods and compositions are designed to diagnose and treat diseases associated with hypoxia-induced injuries. Additionally, they can be utilized to modulate cell pluripotency or differentiation both in vivo and in vitro.
Career Highlights
Andrew M Intlekofer is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to advance his research in the field of cancer and metabolism. His work has garnered attention for its potential applications in medical diagnostics and therapeutic strategies.
Collaborations
One of his notable collaborators is Craig B Thompson, who shares a commitment to advancing cancer research and treatment methodologies.
Conclusion
Andrew M Intlekofer's contributions to the field of stress-induced metabolism and his innovative patents highlight his role as a leading inventor in medical research. His work continues to pave the way for new diagnostic and therapeutic approaches in treating stress-related injuries.